Aurora Cannabis Expected to Post FY2021 Earnings of ($1.05) Per Share

Aurora Cannabis Inc. (ACB.TO) (TSE:ACB) – Cantor Fitzgerald increased their FY2021 EPS estimates for Aurora Cannabis Inc. (ACB.TO) in a research note issued to investors on Monday, November 9th.

Cantor Fitzgerald analyst P. Zuanic now expects that the company will post earnings of ($1.05) per share for the year, up from their previous forecast of ($1.40). Cantor Fitzgerald has a “Neutral” rating on the stock.

A number of other research analysts also recently commented on the stock. Pi Financial lowered their price target on shares of Aurora Cannabis Inc. (ACB.TO) from C$12.00 to C$10.00 and set a “neutral” rating for the company in a report on Wednesday, September 23rd. Atb Cap Markets downgraded shares of Aurora Cannabis Inc. (ACB.TO) from a “sector perform” rating to an “underperform” rating in a report on Monday. CIBC increased their price target on shares of Aurora Cannabis Inc. (ACB.TO) from C$12.00 to C$15.00 in a report on Tuesday. Stifel Nicolaus lowered their price target on shares of Aurora Cannabis Inc. (ACB.TO) from C$10.50 to C$3.60 in a report on Wednesday, October 28th. Finally, Cowen increased their price target on shares of Aurora Cannabis Inc. (ACB.TO) from C$10.00 to C$16.00 in a report on Tuesday. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company’s stock. Aurora Cannabis Inc. (ACB.TO) currently has an average rating of “Hold” and a consensus target price of C$9.72.

Shares of Aurora Cannabis Inc. (ACB.TO) stock opened at C$9.18 on Wednesday. The firm has a market cap of $1.47 billion and a price-to-earnings ratio of -0.28. The business has a 50-day moving average price of C$6.88 and a 200-day moving average price of C$11.91. The company has a quick ratio of 0.98, a current ratio of 1.88 and a debt-to-equity ratio of 23.54. Aurora Cannabis Inc. has a twelve month low of C$4.93 and a twelve month high of C$54.60.

Aurora Cannabis Inc. (ACB.TO) Company Profile

Aurora Cannabis Inc produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Share: